
Robert Huddart, professor, The Institute of Cancer Research, discusses the HYBRID trial which assessed hypofractionated bladder radiotherapy with or without image guided adaptive planning in elderly patients with bladder cancer.

Your AI-Trained Oncology Knowledge Connection!


Published: March 6th 2017 | Updated: